Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea
about
Mechanical stimulation activates Galphaq signaling pathways and 5-hydroxytryptamine release from human carcinoid BON cellsPharmacology and clinical experience with alosetron.Ramosetron in irritable bowel syndrome with diarrhea: new hope or the same old story?LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotoninEffects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans.Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trialSerotonin is a sword and a shield of the bowel: serotonin plays offense and defensePurinergic receptors and gastrointestinal secretomotor function.A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia.Management of the hormonal syndrome of neuroendocrine tumors.Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers.Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro.Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats.Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome.
P2860
Q28360745-DE987DEB-CEBE-4718-9DF1-063170BECFEFQ31521286-73CDCDE5-254C-4110-BD7B-82222B072320Q33656496-D6533C0A-2D46-466D-BF61-3EE5D92DE26EQ34790812-C24F3690-38BA-496E-871F-D4A2D840815FQ35361939-A7B7D3A0-FA7B-4095-9287-4D21C981A1E0Q36055161-4F3E9DF2-6278-44F9-A475-B19C38F251E6Q36519716-D361235D-55A1-4430-8DCF-E2FA68468CDBQ36793761-4058D233-69D4-4003-AEA2-7C0AB03CAA73Q39420214-615A111A-69ED-45F5-8F9D-53FD6BBE5DD8Q41832570-2978719B-BB31-49D8-8708-88FCDC8931CAQ43352672-0A4C7926-6B9E-4F44-8E0B-03171131FCA7Q43737841-E6A56318-DC52-42FC-898C-815882595504Q44391164-6E3DE772-2749-489C-B326-3A9D47801FDDQ53755018-F612EE81-2EA7-4C3C-93C6-471FD7E238B0
P2860
Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Medium-term effects of a new 5 ...... ients with carcinoid diarrhoea
@ast
Medium-term effects of a new 5 ...... ients with carcinoid diarrhoea
@en
type
label
Medium-term effects of a new 5 ...... ients with carcinoid diarrhoea
@ast
Medium-term effects of a new 5 ...... ients with carcinoid diarrhoea
@en
prefLabel
Medium-term effects of a new 5 ...... ients with carcinoid diarrhoea
@ast
Medium-term effects of a new 5 ...... ients with carcinoid diarrhoea
@en
P2093
P2860
P356
P1433
P1476
Medium-term effects of a new 5 ...... ients with carcinoid diarrhoea
@en
P2093
D D Burton
G M Thomforde
J S Scolapio
L A Forstrom
M Camilleri
S B Saslow
P2860
P304
P356
10.1136/GUT.42.5.628
P407
P577
1998-05-01T00:00:00Z